These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 11378571)

  • 1. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
    Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
    Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
    Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
    Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
    Rubio R
    Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors.
    Andrieu JM; Roithmann S; Tourani JM; Levy R; Desablens B; le Maignan C; Gastaut JA; Brice P; Raphael M; Taillan B
    Ann Oncol; 1993 Sep; 4(8):635-41. PubMed ID: 8240994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
    Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
    J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
    Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G
    Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease in the setting of human immunodeficiency virus infection.
    Calza L; Manfredi R; Colangeli V; Dentale N; Chiodo F
    Scand J Infect Dis; 2003; 35(2):136-41. PubMed ID: 12693568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
    Tirelli U; Errante D; Dolcetti R; Gloghini A; Serraino D; Vaccher E; Franceschi S; Boiocchi M; Carbone A
    J Clin Oncol; 1995 Jul; 13(7):1758-67. PubMed ID: 7541452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
    Errante D; Gabarre J; Ridolfo AL; Rossi G; Nosari AM; Gisselbrecht C; Kerneis Y; Mazzetti F; Vaccher E; Talamini R; Carbone A; Tirelli U
    Ann Oncol; 1999 Feb; 10(2):189-95. PubMed ID: 10093688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
    Straus DJ; Huang J; Testa MA; Levine AM; Kaplan LD
    J Clin Oncol; 1998 Nov; 16(11):3601-6. PubMed ID: 9817281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
    Sharma A; Bajpai J; Raina V; Mohanti BK
    Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
    Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
    J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).
    Errante D; Tirelli U; Gastaldi R; Milo D; Nosari AM; Rossi G; Fiorentini G; Carbone A; Vaccher E; Monfardini S
    Cancer; 1994 Jan; 73(2):437-44. PubMed ID: 7507401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.
    D'Addario G; Dieterle A; Torhorst J; Maibach R; Stahel R; Egli F; Lohri A; Cavalli F; Fey M; Ketterer N; Cerny T
    Leuk Lymphoma; 2003 Jan; 44(1):133-8. PubMed ID: 12691153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
    Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
    J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
    Tanaka PY; Pracchia LF; Calore EE
    Int J Hematol; 2006 Nov; 84(4):337-42. PubMed ID: 17118760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.